Wednesday AM Update: Tuesday box office figures To all the cynics out there who believe that the pandemic and streaming have annihilated theatrical moviegoing, well, Sony/Marvel’s Spider-Man: No Way Home just beat the final $515.2M domestic total of 2019’s Star Wars: The Rise of Skywalker with $516.4M. With $1.16 billion worldwide, No Way Home is officially Sony’s top-grossing movie ever, unseating 2019’s Spider-Man: Far from Home‘s $1.13 billion final global total.
Internationally, the film grossed $28.4 million on Tuesday, bringing its cume to $644.9M.
Rise of Skywalker was one of the last pre-pandemic tentpoles (yes, along with Sonic the Hedgehog, 1917 and Bad Boys for Life) before movie theaters shut down due to Covid. Spider-Man: No Way Home accomplished this feat in 12 days stateside, whereas it took Rise of Skywalker 91 days. No Way Home is also the highest-domestic-grossing film ever for Sony, No. 14 on the all-time list at the domestic box office, and the No. 5 MCU title of all time stateside.
Sony reports No Way Home‘s Tuesday at a $21.3M, -14% from the studio’s reported Monday of $24.75M. Among the second Tuesdays for big Christmas movies, No Way Home ranks fourth behind 2015’s Star Wars: The Force Awakens ($29.5M), 2017’s Star Wars: The Last Jedi ($27.7M) and 2016’s Rogue One: A Star Wars Story ($22.5M).
If that isn’t dazzling enough for you, take a look at the 12-day running domestic B.O. for the Jon Watts-directed sequel: At $516.4M, No Way Home is running 9% ahead of 2018’s Avengers: Infinity War ($472M/final B.O. $678.8M), 22% ahead of Last Jedi ($423.3M/final $620.1M) and 52% ahead of Rogue One ($340.6M/final $532.1M, a number which Spidey will beat soon). No Way Home through 12 days also is pacing ahead of Black Panther by 22% ($421.9M/final $700M). Against the two top-grossing movies of all time at the domestic B.O., Force Awakens ($936.6M) and 2019’s Avengers: Endgame ($858.3M), No Way Home is respectively trailing them by -14% and -20%. Overall, stateside No Way Home is third-fastest movie ever to reach $500M.
Spider-Man: No Way Home is expected to have a better third-weekend U.S./Canada hold than the -68% it saw in Weekend 2. Slower ticket sales on Christmas Eve accounted for lower-than-expected numbers. Business should be better this weekend despite New Year’s Eve on Friday.
In second place on Tuesday was Illumination/Universal’s Sing 2 with $7.8M, +5% from Monday, for a week’s total of $54.78M. That’s 41% behind the first Sing‘s seven days of $93M, which also opened on a Wednesday, but 27% ahead of the first seven days of Disney’s Thanksgiving Wednesday opener Encanto ($43.2M, current running total $89.3M).
Warner Bros./Village Roadshow’s The Matrix Resurrections, also playing in homes on HBO Max, is seeing an estimated Tuesday of $1.6M, -6% from Monday, for a 7-day of $24.5M.
20th Century Studios/Disney’s The King’s Man looks to have charted $1.4M in fourth place, up from Disney’s reported $1.38M Monday, for a 7-day tally of $12.4M. Note, Matthew Vaughn’s MARV financed the prequel, and 20th Century Studios/Disney takes a distribution fee. The big question is that after Disney misfired on this prequel, is there any future for The Kingsmen? Or is it all on Hulu and Disney+?
Holiday business hasn’t been kind to 20th/Amblin/Disney’s Steven Spielberg musical West Side Story, which saw an estimated $874K on Tuesday in sixth place, -3% from Monday’s $903K for a running total of $25.7M. Again a movie challenged by older audiences (35+) who aren’t ready to come out to the theaters during the Omicron surge. Note that these musicals typically play in the Northeast, and as NRG reported last weekend, that’s one section of the country that’s fearful to attend cinemas right now.
In fifth is Lionsgate’s American Underdog, which is an adult film that’s holding up with $1.29M, +2% from Monday. That’s because it’s playing to the red states, where people largely are fearless about the pandemic. The Erwin Brothers’ directed movie’s 4-day gross is $8.4M.
Subscribe to Deadline Breaking News Alerts and keep your inbox happy.